Clinical Trial Update: HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating HLA-B*58:01-guided therapy for gout to assess effectiveness, safety, and cost-effectiveness; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Haiphong University of Medicine and Pharmacy | Conditions: Gout Initiating Urate-loweringUrate-lowering Therapy, Gout Arthritis | Phase 4 | Status: NOT_YET_RECRUITING